Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,066,843    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $65,005,693      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,940 Incyte Corp $895,340 Immunome Inc. $143,648
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 31 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-27 4 OE $14.39 $863,400 D/D 60,000 383,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-28 4 OE $14.39 $863,400 D/D 60,000 383,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 AS $89.52 $895,200 D/D (10,000) 296,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-29 4 AS $89.61 $896,125 D/D (10,000) 225,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-12-28 4 AS $89.89 $898,912 D/D (10,000) 225,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-01-05 4 AS $90.32 $903,203 D/D (10,000) 225,894 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2023-12-21 4 AS $93.99 $939,900 D/D (10,000) 425,112 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-08 4 OE $63.10 $946,500 D/D 15,000 434,602 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-09 4 OE $63.10 $946,500 D/D 15,000 434,602 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-14 4 AS $86.89 $955,814 D/D (11,000) 323,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-20 4 D $73.05 $959,000 D/D (13,128) 297,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-06 4 AS $96.13 $961,300 D/D (10,000) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-10 4 AS $96.38 $963,800 D/D (10,000) 425,162 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-11 4 S $38.01 $969,656 D/D (25,500) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-09 4 AS $98.19 $981,900 D/D (10,000) 425,162 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-10 4 AS $99.56 $995,600 D/D (10,000) 425,896 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-10 4 OE $67.81 $1,017,150 D/D 15,000 335,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-10 4 OE $67.81 $1,017,150 D/D 15,000 502,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 S $70.17 $1,052,492 I/I (15,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4 D $81.36 $1,063,782 D/D (13,075) 284,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4/A D $81.36 $1,068,013 D/D (13,127) 283,979 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-17 4 AS $111.55 $1,115,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-13 4 AS $112.25 $1,122,500 D/D (10,000) 320,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-05 4 S $113.70 $1,137,016 I/I (10,000) 42,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-22 4 D $88.05 $1,155,832 D/D (13,127) 323,211 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  32   33   34   35      
  Page 31 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us